AMSBIO has published an interview with Professor Marius Wernig from Stanford University, Pathology Stem Cell Institute that discusses what could be the world’s first widely applicable curative treatment for Epidermolysis Bullosa (EB). This rare genetic disease causes chronic and incredibly painful skin wounds that often lead to an aggressive form of skin cancer and eventual death...
Evident, a wholly owned subsidiary of Olympus Corporation, announced its fourth Global Image of the Year Scientific Light Microscopy Award is now open for entries through Feb. 28, 2023. Each year, the competition recognizes the best in scientific imaging worldwide. For the first time, the contest welcomes materials science images in addition to life science images to show the versatility of the art of science...
ZEISS experts Dr. Thomas Kalkbrenner, Dr. Jörg Siebenmorgen and Ralf Wolleschensky have been nominated for the 2022 German Future Prize. Their project: the innovative microscope ZEISS Lattice Lightsheet 7 for the gentle 3D imaging of living cells. By combining imaging that protects samples with high resolution, the system allows researchers to observe subcellular dynamics in 3D over hours and days, which was not previously possible with other microscopy technologies....
McCrone Microscopes & Accessories will present a range of Linkam’s leading temperature and environment-controlled stages at booth #1134, AMS 2022. The Linkam Modular Force Stage (MFS) is designed to gain a better understanding of a material’s behaviour under different temperature, mechanical stress and environmental conditions. The system offers advanced sensitivity, high resolution and a modular concept for customised experiment design and control...
The Chairmen and Organizers of the 51st International Symposium on High-Performance Liquid Phase Separations and Related Techniques (HPLC 2023) are delighted to announce the conference dates and details for the upcoming 2023 edition of the HPLC symposium series. Since its first edition in 1973, the HPLC symposium series has established itself as the world’s leading scientific conference on high-performance liquid phase separations and related techniques...
Jacobs was selected as full lifecycle delivery partner to support infrastructure renewal projects at various facilities run by the U.K.’s government owned, but operationally independent, National Nuclear Laboratory (NNL). NNL estimates the contract value at $12 million (£10 million) and the initial contract term is one year with options for three additional one-year extensions. Scope includes design, build and refurbishment work at the Windscale and Central Laboratories at Sellafield in Cumbria...
The next competition is officially open at INTEGRA Biosciences. The company is giving away a comprehensive ASSIST PLUS pipetting robot package that includes a D-ONE single channel pipetting module. The innovative ASSIS PLUS pipetting robot enables elegant automation of repetitive tasks to increase throughput in your lab...
This webcast is targeted at laboratories who are planning to implement a new LIMS, either for the first time or as a replacement for an aging LIMS that is no longer meeting the organization's business needs. Where do you start and what evaluation factors are most important? We will answer those questions as well as providing advice that will help ensure you make the right LIMS selection...
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announces its continuing commitment to the next generation of researchers and scientists with a call for registrations for its SPRI Grants for Genomic Research. Reinforcing its dedication to providing streamlined genomic workflow solutions, the company will award up to eight grants in 2022...
The Franklin is the national institute developing disruptive new technologies designed to tackle major challenges in health and life sciences. The competition aims to make these technologies – and the expertise of Franklin scientists – available to a small company in the UK to help them overcome a specific research challenge. The winning company will take part in a 12-week residency starting in April 2023, working with Franklin scientists to use technologies at the cutting edge of the field...
Aseptic Process solutions specialist Telstar will be expanding its facilities with the construction of three additional modules, adjacent to the building where the headquarters are currently located. The result will be a modern industrial site based on a total floor area of 16,000 m2, which will accommodate all the current activity of the company in Catalonia. A total of 70% of the space will be intended for production plants...
RQM+, the leading MedTech service provider with the world’s largest global team of regulatory and quality experts, and portfolio company of Linden Capital Partners, has announced the acquisition of Jordi Labs. With these new capabilities, RQM+ provides comprehensive regulatory, quality, clinical and laboratory services, supporting market access throughout the entire product lifecycle for medical devices and diagnostics....
Researchers at the Australian National Phenome Centre (ANPC) at Murdoch University have successfully detected and quantified newly discovered biomarkers of SARS-CoV-2 acute infections and of ‘Long COVID’. They used a benchtop Fourier Transform-nuclear magnetic resonance (FT-NMR) spectrometer with a permanent magnet, thereby lowering the barrier to clinical translation of this epidemiological and diagnostic research technology...
The COVID-19 pandemic has put a spotlight on the dangers of misinformation in the science industry. This phenomenon has been amplified with the popularity of forums and platforms that act as news distribution networks without a filter or editorial oversight. Here Aleiya Lonsdale, Head of Event at the largest laboratory event in the UK, Lab Innovations 2022, discusses how the lab community has tried to hold back against the tide of scientific misinformation.
The Institute of Cancer Research, London, has expressed disappointment that NICE has confirmed its decision not to recommend olaparib for previously treated, hormone-relapsed metastatic prostate cancer. NICE’s decision means that men in England and Wales with prostate cancer will miss out on a highly innovative treatment option. It puts the NHS in England and Wales out of step with Scotland, where olaparib was approved last year for the treatment of prostate cancers with faulty DNA repair genes...
Plant-derived ring peptide and its variants show anti-tumor activity against lymphoma cells. Oncological study with participation of KL Krems. An Austrian study demonstrates an anti-tumor effect of certain nature-derived cyclic peptides. The study, which has now been published internationally, not only demonstrates the inhibition of cell division by these peptides, but even their ability to cause cell death of cancer cells...
Minderoo Foundation and Illumina, Inc. have announced a 40 million Australian dollar (US $27.8 million) partnership that will leverage the power of genomics to accelerate scientific understanding of marine systems and help marine conservationists make informed decisions. The three-year partnership demonstrates a shared commitment to conserving marine biodiversity and understanding the changing marine ecosystems on which people and national economies depend...
Modified version of herpes simplex virus shows promise against range of advanced cancers in early trial results A new genetically engineered virus has delivered a one-two punch against advanced cancers in initial findings from a phase I trial. Researchers found that RP2 – a modified version of the herpes simplex virus – showed signs of effectiveness in a quarter of patients with a range of advanced cancers...
CloudLIMS, a leading SaaS company offering secure, configurable, high-quality lab informatics solutions, proudly announces that it has completed the Service Organization Control (SOC 2) Type II audit. An independent, third-party Certified Public Accounting (CPA) firm carried out the SOC 2 Type II audit at CloudLIMS. The third-party approval stamps our continued commitment to offer a Laboratory Information Management System (LIMS) with the best information security offered in the industry...
As a pioneer in the industry, FRITSCH have poured 35 years of experience in particle sizing technology into the new FRITSCH Technology Centre for Particle Sizing, combining it with the latest high-end technology. Covering an area of 240 m2 on three floors, the new building at the FRITSCH headquarters in Idar-Oberstein/Germany offers plenty of room for the entire FRITSCH particle sizing team, bringing together development and application technology...
Evident, a wholly owned subsidiary of Olympus Corporation, announced the latest results from its ongoing joint research program to create an AI-based pathology diagnostic tool at the 20th annual meeting of the Japanese Society of Digital Pathology. The results show the diagnostic tool in development succeeded in expanding its AI detection to seven types of gastric cancer, highlighting its versatility for a range of pathology applications....
Merck, a leading science and technology company, strengthens its manufacturing capabilities for single-use assemblies, a key technology for the production of Covid-19 vaccines and other lifesaving therapies, by investing more than € 130 million in Molsheim, France. The investment is the largest ever in the 50-year history of the site and will create more than 800 jobs by the end of 2028...
AMSBIO has published an interview with Professor Marius Wernig from Stanford University, Pathology Stem Cell Institute that discusses what could be the world’s first widely applicable curative treatment for Epidermolysis Bullosa (EB). This rare genetic disease causes chronic and incredibly painful skin wounds that often lead to an aggressive form of skin cancer and eventual death...
Evident, a wholly owned subsidiary of Olympus Corporation, announced its fourth Global Image of the Year Scientific Light Microscopy Award is now open for entries through Feb. 28, 2023. Each year, the competition recognizes the best in scientific imaging worldwide. For the first time, the contest welcomes materials science images in addition to life science images to show the versatility of the art of science...
ZEISS experts Dr. Thomas Kalkbrenner, Dr. Jörg Siebenmorgen and Ralf Wolleschensky have been nominated for the 2022 German Future Prize. Their project: the innovative microscope ZEISS Lattice Lightsheet 7 for the gentle 3D imaging of living cells. By combining imaging that protects samples with high resolution, the system allows researchers to observe subcellular dynamics in 3D over hours and days, which was not previously possible with other microscopy technologies....
McCrone Microscopes & Accessories will present a range of Linkam’s leading temperature and environment-controlled stages at booth #1134, AMS 2022. The Linkam Modular Force Stage (MFS) is designed to gain a better understanding of a material’s behaviour under different temperature, mechanical stress and environmental conditions. The system offers advanced sensitivity, high resolution and a modular concept for customised experiment design and control...
The Chairmen and Organizers of the 51st International Symposium on High-Performance Liquid Phase Separations and Related Techniques (HPLC 2023) are delighted to announce the conference dates and details for the upcoming 2023 edition of the HPLC symposium series. Since its first edition in 1973, the HPLC symposium series has established itself as the world’s leading scientific conference on high-performance liquid phase separations and related techniques...
Jacobs was selected as full lifecycle delivery partner to support infrastructure renewal projects at various facilities run by the U.K.’s government owned, but operationally independent, National Nuclear Laboratory (NNL). NNL estimates the contract value at $12 million (£10 million) and the initial contract term is one year with options for three additional one-year extensions. Scope includes design, build and refurbishment work at the Windscale and Central Laboratories at Sellafield in Cumbria...
The next competition is officially open at INTEGRA Biosciences. The company is giving away a comprehensive ASSIST PLUS pipetting robot package that includes a D-ONE single channel pipetting module. The innovative ASSIS PLUS pipetting robot enables elegant automation of repetitive tasks to increase throughput in your lab...
This webcast is targeted at laboratories who are planning to implement a new LIMS, either for the first time or as a replacement for an aging LIMS that is no longer meeting the organization's business needs. Where do you start and what evaluation factors are most important? We will answer those questions as well as providing advice that will help ensure you make the right LIMS selection...
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announces its continuing commitment to the next generation of researchers and scientists with a call for registrations for its SPRI Grants for Genomic Research. Reinforcing its dedication to providing streamlined genomic workflow solutions, the company will award up to eight grants in 2022...
The Franklin is the national institute developing disruptive new technologies designed to tackle major challenges in health and life sciences. The competition aims to make these technologies – and the expertise of Franklin scientists – available to a small company in the UK to help them overcome a specific research challenge. The winning company will take part in a 12-week residency starting in April 2023, working with Franklin scientists to use technologies at the cutting edge of the field...
Aseptic Process solutions specialist Telstar will be expanding its facilities with the construction of three additional modules, adjacent to the building where the headquarters are currently located. The result will be a modern industrial site based on a total floor area of 16,000 m2, which will accommodate all the current activity of the company in Catalonia. A total of 70% of the space will be intended for production plants...
RQM+, the leading MedTech service provider with the world’s largest global team of regulatory and quality experts, and portfolio company of Linden Capital Partners, has announced the acquisition of Jordi Labs. With these new capabilities, RQM+ provides comprehensive regulatory, quality, clinical and laboratory services, supporting market access throughout the entire product lifecycle for medical devices and diagnostics....
Researchers at the Australian National Phenome Centre (ANPC) at Murdoch University have successfully detected and quantified newly discovered biomarkers of SARS-CoV-2 acute infections and of ‘Long COVID’. They used a benchtop Fourier Transform-nuclear magnetic resonance (FT-NMR) spectrometer with a permanent magnet, thereby lowering the barrier to clinical translation of this epidemiological and diagnostic research technology...
The COVID-19 pandemic has put a spotlight on the dangers of misinformation in the science industry. This phenomenon has been amplified with the popularity of forums and platforms that act as news distribution networks without a filter or editorial oversight. Here Aleiya Lonsdale, Head of Event at the largest laboratory event in the UK, Lab Innovations 2022, discusses how the lab community has tried to hold back against the tide of scientific misinformation.
The Institute of Cancer Research, London, has expressed disappointment that NICE has confirmed its decision not to recommend olaparib for previously treated, hormone-relapsed metastatic prostate cancer. NICE’s decision means that men in England and Wales with prostate cancer will miss out on a highly innovative treatment option. It puts the NHS in England and Wales out of step with Scotland, where olaparib was approved last year for the treatment of prostate cancers with faulty DNA repair genes...
Plant-derived ring peptide and its variants show anti-tumor activity against lymphoma cells. Oncological study with participation of KL Krems. An Austrian study demonstrates an anti-tumor effect of certain nature-derived cyclic peptides. The study, which has now been published internationally, not only demonstrates the inhibition of cell division by these peptides, but even their ability to cause cell death of cancer cells...
Minderoo Foundation and Illumina, Inc. have announced a 40 million Australian dollar (US $27.8 million) partnership that will leverage the power of genomics to accelerate scientific understanding of marine systems and help marine conservationists make informed decisions. The three-year partnership demonstrates a shared commitment to conserving marine biodiversity and understanding the changing marine ecosystems on which people and national economies depend...
CloudLIMS, a leading SaaS company offering secure, configurable, high-quality lab informatics solutions, proudly announces that it has completed the Service Organization Control (SOC 2) Type II audit. An independent, third-party Certified Public Accounting (CPA) firm carried out the SOC 2 Type II audit at CloudLIMS. The third-party approval stamps our continued commitment to offer a Laboratory Information Management System (LIMS) with the best information security offered in the industry...
As a pioneer in the industry, FRITSCH have poured 35 years of experience in particle sizing technology into the new FRITSCH Technology Centre for Particle Sizing, combining it with the latest high-end technology. Covering an area of 240 m2 on three floors, the new building at the FRITSCH headquarters in Idar-Oberstein/Germany offers plenty of room for the entire FRITSCH particle sizing team, bringing together development and application technology...
Evident, a wholly owned subsidiary of Olympus Corporation, announced the latest results from its ongoing joint research program to create an AI-based pathology diagnostic tool at the 20th annual meeting of the Japanese Society of Digital Pathology. The results show the diagnostic tool in development succeeded in expanding its AI detection to seven types of gastric cancer, highlighting its versatility for a range of pathology applications....
Merck, a leading science and technology company, strengthens its manufacturing capabilities for single-use assemblies, a key technology for the production of Covid-19 vaccines and other lifesaving therapies, by investing more than € 130 million in Molsheim, France. The investment is the largest ever in the 50-year history of the site and will create more than 800 jobs by the end of 2028...